Tendersinfo Gulf

Filter Search

Europe

Location Summary Deadline
Germany Open House Drug Discount Agreements For The Active Ingredient Haloperidol, Atc N05ad01 2026-08-15
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Levothyroxine, Atc H03aa01 For The Period 01.04.2026 - 31.03.2028 (plus Extension Option 1x12 Months) 2026-08-15
Germany Open House Drug Discount Agreements Filgrastim, Atc L03aa02 2026-08-15
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredient Pridinol, Atc M03bx03 For The Period April 1st, 2026 - March 31st, 2028 (plus Extension Option 1x12 Months) 2026-08-15
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredient Tranylcypromine, Atc N06af04 For The Period April 1st, 2026 - March 31st, 2028 (plus Extension Option 1x12 Months) 2026-08-15
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Estradiol + Dydrogesterone, Atc G03fa14 For The Period 01.04.2026 - 31.03.2028 (plus V.-option 1x12 Months) 2026-08-15
Germany Open House Drug Discount Agreements For The Active Ingredients Norethisterone And Estrogen, Atc G03fa01 2026-08-15
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredient Estradiol + Dydrogesterone, Atc G03fa14 For The Period April 1st, 2026 - March 31st, 2028 (plus V. Option 1x12 Months) 2026-08-15
Germany Open House Drug Discount Agreements Multienzymes (lipase, Protease Etc.), Atc A09aa02 2026-08-15
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredient Betamethasone + Gentamicin, Atc D07cc01 F. D. Z. 01.04.26 - 31.03.28 (plus Extension Option 1x12 Months) 2026-08-15
Whats app